SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

CNS Pharmacology

» Start this Course
(Practice similar questions for free)
Question:

Zonisamide pharmacokinetics and adverse effects

Author: Suzuki



Answer:

Cross reactivity with other sulfonamides should be reviewed. Its use should be monitored in patients with reported allergies. Zonisamide is approved for use in patients with partial epilepsy. It is metabolized by the CYP3A4 isozyme and may, to a lesser extent, be affected by CYP3A5 and CYP2C19. In addition to typical CNS adverse effects, zonisamide may cause kidney stones. Oligohidrosis has been reported, and patients should be monitored for increased body temperature and decreased sweating.


0 / 5  (0 ratings)

1 answer(s) in total

Author

Suzuki
Suzuki